Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

WHO warns of falsified DESREM (Remdesivir)

The genuine manufacturer of DESREM, Mylan Laboratories Ltd, has confirmed that the products identified in this Alert are falsified. Falsified DESREM (Remdesivir) identified in...

China Meheco signs deal with Pfizer to supply Covid-19 pill

China Meheco Group Co Ltd signed an agreement with Pfizer Inc to supply the latter's COVID-19 treatment Paxlovid in the Chinese mainland in 2022,...

WHO: COVID-19 vaccines in the context of the circulation of the Omicron

The World Health Organization, with the support of the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), continues to review and assess the public...

SHINE and ImaginAb sign clinical supply agreement for lutetium-177 to drive innovation in cancer treatment

SHINE Technologies, a next-generation nuclear technology company, and ImaginAb Inc., a market-leading global biotechnology company focused on developing next-generation immuno-oncology imaging agents and therapeutic...

New investigational immunotherapy method for the treatment of patients with glioblastoma

Sharp HealthCare is a not-for-profit regional health care group, in collaboration with Nascent Biotech, Inc, a company pioneering the development of monoclonal antibodies, announced...

Novartis and Voyager Therapeutics announce partnership to develop next-generation gene therapy for neurological diseases

Novartis today announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids...
spot_img

Expert Articles

spot_img